Cannaisseur Group Inc. (TCRG)
TCRG is quoted over the counter, not listed on an exchange. Cannaisseur Group Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Profile
| Field | Value |
|---|---|
| Ticker | TCRG, quoted over the counter |
| SEC CIK | 0001879270 |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Business address | Atlanta, GA |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time." | 10-Q 2026-11-13 |
| Cash and burn | $41 cash; operating cash flow -$28K a quarter. | Report 2026-06-30 |
| Shares outstanding | 60,459,890 (2026-11-09); 60,459,890 a year earlier; 40,577,619 three years earlier. | Cover page 2026-11-09 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | M&K CPAS, PLLC, The Woodlands, Texas, United States | PCAOB Form AP 2026-03-24 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $0 | -$95K | -$30K | $41 | $8K | $0 | 10-Q 2026-08-12 |
| Q1 2026 2026-03-31 | $0 | -$102K | -$40K | $45 | $8K | $0 | 10-Q 2026-05-11 |
| Q4 2025 2025-12-31 | $0 | -$101K | -$20K | $22 | $7K | $0 | 10-K 2026-03-23 |
| Q3 2025 2025-09-30 | $0 | -$745K | -$21K | $143 | $7K | $0 | 10-Q 2025-11-18 |
| Q2 2025 2025-06-30 | $0 | -$79K | -$18K | $3K | $7K | $285 | 10-Q 2026-08-12 |
| Q1 2025 2025-03-31 | $0 | -$849K | -$69K | $20K | $7K | $285 | 10-Q 2026-05-11 |
| Q4 2024 2024-12-31 | $0 | -$90K | -$12K | $563 | $7K | $700 | 10-K 2026-03-23 |
| Q3 2024 2024-09-30 | $285 | -$22K | -$11K | $532 | $118K | $1K | 10-Q 2025-11-18 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | POS AM | 2025-03-27 |
| Latest annual report | 10-K | 2026-03-23 |
| Latest quarterly / interim | 10-Q | 2026-11-13 |
| Latest current report | 8-K | 2025-08-28 |
Source: SEC EDGAR submissions feed, 73 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier